Web Analytics

3 Latest Announced Rounds

  • $6,200,000
    Seed

    4 Investors

    Software Development
    Oct 8th, 2025
  • $8,129,205
    Unknown

    2 Investors

    Robotics Engineering
    Oct 8th, 2025
  • $24,000,000
    Series A

    2 Investors

    Hospital & Health Care
    Oct 8th, 2025
$762.17M Raised in 42 Funding Rounds in the past 7 Days - View All

Funding Round Profile

IMU Biosciences

start up
United Kingdom - London
  • 25/01/2024
  • Series A
  • $14,639,787

Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.


Related People

Adam LaingCo Founder

Adam Laing United Kingdom - London, England

N/A